BuprenorphineDosage FormsTabletsOpioid-Related DisordersNarcotic AntagonistsChemistry, PharmaceuticalOpiate Substitution TreatmentCapsulesExcipientsDelayed-Action PreparationsNarcoticsDrug CompoundingTechnology, PharmaceuticalMorphinansAnalgesics, OpioidAdministration, SublingualNaloxoneMethadonePharmaceutical SolutionsDrug StabilityHeroin DependencePharmaceutical PreparationsSolubilityMethylcelluloseOrnidazoleTablets, Enteric-CoatedPowdersAdministration, OralChromatography, Reverse-PhaseNeonatal Abstinence SyndromeBiological AvailabilityMethadyl AcetatePowder DiffractionChromatography, High Pressure LiquidDrug CombinationsTherapeutic EquivalencySuspensionsHeroinCalibrationNaltrexoneGene DosageSubstance Withdrawal SyndromeReceptors, OpioidDrug CarriersDosage Compensation, GeneticReceptors, Opioid, muLimit of DetectionOxprenololSpectrophotometry, UltravioletDrug Delivery SystemsPolymethacrylic AcidsEmulsionsDrug Administration RoutesDose-Response Relationship, DrugDothiepinPharmacokineticsKetoprofenOpiate AlkaloidsMorphineDrug StorageReproducibility of ResultsLevorphanolSubstance Abuse DetectionParticle SizeAmebicidesThiazinesHumidityAnalgesicsThermogravimetryPrescription Drug DiversionPrescription Drug MisuseNalbuphineGlipizideBiopharmaceuticsCarboxymethylcellulose SodiumSubstance Abuse Treatment CentersPovidoneHydromorphoneLoratadineHardnessVeterinary DrugsCalorimetry, Differential ScanningHexuronic AcidsTriacetinDrug InteractionsGlucuronic AcidAmbroxolAdministration, CutaneousCelluloseAnalgesiaIbuprofenChlorpheniramineReference StandardsDrug and Narcotic ControlStreet DrugsHalf-Lifebeta-CyclodextrinsDouble-Blind Method